Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Effect of High Dose Salbutamol on Muscle Performance

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Bispebjerg Hospital.
Recruitment status was:  Active, not recruiting
University of Copenhagen
Information provided by:
Bispebjerg Hospital Identifier:
First received: August 11, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted

August 11, 2011
August 11, 2011
August 2011
August 2012   (Final data collection date for primary outcome measure)
Muscle power
Same as current
No Changes Posted
Muscle recovery
Same as current
Not Provided
Not Provided
The Effect of High Dose Salbutamol on Muscle Performance
The Effect of High Dose Salbutamol on Dynamic and Isometric Muscle Power and Recovery in Well-trained Males
Many athletes use beta2-agonists as treatment of airway hyperresponsiveness during exercise. High dose beta2-agonists may have an ergogenic effect on exercise performance. We hypotheis that the beta2-agonist, salbutamol, taken in high doses can improve muscle power and recovery during exercise in well-trained athletes.
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator)
Ergogenic Effects of Salbutamol in Healthy Males
  • Drug: salbutamol
  • Drug: Placebo
  • Placebo Comparator: Placebo
    Intervention: Drug: Placebo
  • Active Comparator: Salbutamol
    Intervention: Drug: salbutamol
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Unknown status
August 2013
August 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Males
  • age 18-45
  • training frequency > 10 hrs/wk
  • informed consent

Exclusion Criteria:

  • smoker or former smoker
  • chronic diseases, as well as asthma
  • allergy to the study drugs
  • intake of any form of medicin or inhibited drugs during the study
  • use of beta2-agonist 14 days before the intervention
Sexes Eligible for Study: Male
18 Years to 45 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Vibeke Backer, Bispebjerg Hospital
Bispebjerg Hospital
University of Copenhagen
Not Provided
Bispebjerg Hospital
March 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP